Mays v. Bishop et al

Filing 31

STIPULATION AND ORDER STAYING ACTION PENDING OUTCOME OF ANNOUNCED ACQUISITION OF DEFENDANT JUNO THERAPEUTICS, INC. signed by Judge Ricardo S Martinez. The briefing schedule on Defendants' 28 Motion to Transfer is vacated; All other pretrial proceedings are stayed. (PM)

Download PDF
1 2 3 4 5 6 7 8 9 10 UNITED STATES DISTRICT COURT WESTERN DISTRICT OF WASHINGTON IN RE JUNO THERAPEUTICS, INC. DERIVATIVE LITIGATION Lead Case No.: C17-1356 RSM (Derivative Action) This Document Relates To: STIPULATED MOTION AND ORDER STAYING ACTION PENDING OUTCOME OF ANNOUNCED ACQUISITION OF DEFENDANT JUNO THERAPEUTICS, INC. 11 12 13 14 ALL ACTIONS. 15 16 17 18 19 20 21 22 23 24 25 26 27 28 STIPULATED MOTION AND ORDER STAYING ACTION PENDING OUTCOME OF ANNOUNCED ACQUISITION OF JUNO THERAPEUTICS, INC. LEAD CASE NO.: C17-1356 RSM WILSON SONSINI GOODRICH & ROSATI, P.C. 701 Fifth Avenue, Suite 5100, Seattle, WA 98104-7036 Tel: (206) 883-2500 • Fax: (206) 883-2699 Defendants Hans E. Bishop, Richard D. Klausner, Robert T. Nelsen, Howard H. Pien, Hal 1 2 V. Barron, Thomas O. Daniel, Anthony B. Evnin, Mary Agnes Wilderotter, Marc Tessier- 3 Lavigne, Steven D. Harr, and Mark J. Gilbert, and Nominal Defendant Juno Therapeutics, Inc. 4 (“Juno”) (collectively, “Defendants”), and plaintiffs David E. Mays and Paul Szollosi 5 (collectively, “Plaintiffs”), by and through their respective counsel, submit this Stipulated Motion 6 and Proposed Order pursuant to LR 10(g): WHEREAS, on September 8, 2017, Plaintiff David E. Mays filed a putative shareholder 7 8 derivative action purportedly on behalf of Juno, and on November 6, 2017, Plaintiff Paul Szollosi 9 filed a similar putative shareholder derivative action purportedly on behalf of Juno; 10 WHEREAS, on December 5, 2017, the Court consolidated the two actions and ordered a 11 briefing schedule for Defendants’ Motion to Transfer (“Motion”), with Defendants’ motion to be 12 filed no more than fourteen days after the order, Plaintiffs’ opposition to be filed no more than 45 13 days later, and Defendants’ reply to be filed no more than 30 days after Plaintiffs’ opposition is 14 filed (Dkt. 27); WHEREAS, pursuant to the December 5, 2017 consolidation order, Defendants filed their 15 16 Motion on December 19, 2017 (Dkt. 28); 17 WHEREAS, on January 22, 2018, Juno and Celgene Corporation (“Celgene”) announced 18 the signing of a definitive merger agreement in which Celgene has agreed to acquire Juno for $87 19 per share in cash (the “Acquisition”) pursuant to a tender offer for all outstanding shares of Juno 20 (“Tender Offer”); WHEREAS, the Tender Offer is anticipated to close in Q1 2018 (i.e., by the end of March 21 22 23 24 2018); WHEREAS, the parties agree that, if the Tender Offer is completed and the Acquisition closes, Plaintiffs will no longer have standing to pursue these putative derivative actions; 25 WHEREAS, for the purpose of ensuring that this action proceeds in an efficient and 26 orderly fashion, counsel for the parties have conferred and agreed to suspend briefing on the 27 Motion and all other pretrial proceedings herein, pending the outcome of the Tender Offer and 28 STIPULATED MOTION AND ORDER STAYING ACTION PENDING OUTCOME OF ANNOUNCED ACQUISITION OF JUNO THERAPEUTICS, INC. LEAD CASE NO.: C17-1356 RSM -1- WILSON SONSINI GOODRICH & ROSATI, P.C. 701 Fifth Avenue, Suite 5100, Seattle, WA 98104-7036 Tel: (206) 883-2500 • Fax: (206) 883-2699 1 2 3 4 Acquisition; NOW, THEREFORE, the undersigned parties, by and through their counsel of record, hereby agree and stipulate to the following: 1. The briefing schedule on Defendants’ Motion as ordered by the Court on December 5, 2017 is vacated; 5 6 2. All other pretrial proceedings are stayed; 7 3. In the event the Acquisition fails to close, the parties agree to meet and confer in 8 good faith to agree on a new schedule for the filing of Plaintiffs’ Opposition to the 9 Motion and Defendants’ Reply in support of the Motion, as well as the hearing on 10 the Motion. Respectfully submitted, 11 12 Dated: January 29, 2018 13 14 15 16 Counsel for Defendants 17 18 WILSON SONSINI GOODRICH & ROSATI, PC /s/ Gregory L. Watts Gregory L. Watts, WSBA #43995 701 Fifth Avenue, Suite 5100 Seattle, Washington 98104 Telephone: (206) 883-2500 Facsimile: (206) 883-2699 Email: gwatts@wsgr.com Dated: January 29, 2018 22 ZWERLING, SCHACHTER & ZWERLING, LL /s/ Dan Drachler Dan Drachler (WSBA #27728) 1904 Third Avenue Suite 1030 Seattle, Washington 98101 Telephone: (206) 223-2053 Facsimile: (206) 343-9636 ddrachler@zsz.com 23 Counsel for Plaintiffs 24 HARWOOD FEFFER LLP Robert I. Harwood (pro hac vice) Matthew M. Houston (pro hac vice) Benjamin I. Sachs-Michaels (pro hac vice) 488 Madison Avenue, 8th Floor New York, New York 10001 Telephone: (212) 935-7400 Facsimile: (212) 753-3630 -2- 19 20 21 25 26 27 28 STIPULATED MOTION AND ORDER STAYING ACTION PENDING OUTCOME OF ANNOUNCED ACQUISITION OF JUNO THERAPEUTICS, INC. LEAD CASE NO.: C17-1356 RSM WILSON SONSINI GOODRICH & ROSATI, P.C. 701 Fifth Avenue, Suite 5100, Seattle, WA 98104-7036 Tel: (206) 883-2500 • Fax: (206) 883-2699 rharwood@hfesq.com mhouston@hfesq.com bsachsmichaels@hfesq.com 1 2 GLANCY PRONGAY & MURRAY, LLP Robert V. Prongay Lesley F. Portnoy 1925 Century Park East, Suite 2100 Los Angeles, California 90067 Telephone: (310) 201-9150 Facsimile: (310) 201-9160 rprongay@glancylaw.com lportnoy@glancylaw.com 3 4 5 6 7 Counsel for Plaintiff David E. Mays 8 THE WEISER LAW FIRM, P.C. Robert B. Weiser Brett D. Stecker (pro hac vice) James M. Ficaro (pro hac vice) 22 Cassatt Avenue Berwyn, PA 19312 Telephone: (610) 225-2677 Facsimile: (610) 408-8062 rw@weiserlawfirm.com bds@weiserlawfirm.com jmf@weiserlawfirm.com 9 10 11 12 13 14 Counsel for Plaintiff Paul Szollosi 15 16 17 * * * IT IS SO ORDERED this 31st day of January 2018. A 18 19 RICARDO S. MARTINEZ CHIEF UNITED STATES DISTRICT JUDGE 20 21 22 PRESENTED BY: 23 Gregory L. Watts, WSBA #43995 701 Fifth Avenue, Suite 5100 Seattle, Washington 98104 Telephone: (206) 883-2500 Facsimile: (206) 883-2699 Email: gwatts@wsgr.com 24 25 26 27 28 Counsel for Defendants STIPULATED MOTION AND ORDER STAYING ACTION PENDING OUTCOME OF ANNOUNCED ACQUISITION OF JUNO THERAPEUTICS, INC. LEAD CASE NO.: C17-1356 RSM -3- WILSON SONSINI GOODRICH & ROSATI, P.C. 701 Fifth Avenue, Suite 5100, Seattle, WA 98104-7036 Tel: (206) 883-2500 • Fax: (206) 883-2699

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?